Related Experiment Video
Updated: Jun 5, 2026
Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis
Published on: May 17, 2015
Cardiac transplant graft arteriosclerosis
1Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Insights
Transplant-associated coronary arteriosclerosis is a major cause of late death after heart transplantation. Immunologic mechanisms, involving T-lymphocytes and macrophages, likely drive smooth muscle cell proliferation in these obstructive lesions.
Area of Science:
- Cardiology
- Immunology
- Transplantation
Background:
- Transplant-associated coronary arteriosclerosis (TACA) is a leading cause of late mortality following heart transplantation.
- TACA presents as an obstructive, proliferative lesion in the coronary arteries of transplanted hearts, often developing within months.
- Diagnosis and treatment of TACA are challenging due to graft denervation and the diffuse nature of the lesions.
Purpose of the Study:
- To elucidate the underlying mechanisms and characteristics of transplant-associated coronary arteriosclerosis.
- To differentiate TACA from typical coronary atherosclerosis.
- To identify potential immunologic contributors to TACA development.
Main Methods:
- Morphological analysis of graft arteriosclerotic lesions.
- Examination of cellular components within the lesions, including T-lymphocytes and macrophages.
- Investigation of the role of smooth muscle cells and extracellular matrix in lesion formation.
- Exploration of potential immunologic pathways, such as cytokine-driven proliferation.
Main Results:
- TACA lesions are morphologically distinct from typical coronary atherosclerosis.
- Lesions feature T-lymphocytes and macrophages beneath an intact endothelium.
- Obstructive lesions are primarily composed of smooth muscle cells and extracellular matrix.
- Immunologic mechanisms, potentially involving chronic cell-mediated immune responses, are implicated in TACA pathogenesis.
Conclusions:
- Transplant-associated coronary arteriosclerosis is driven by immunologic mechanisms.
- Cytokine-driven smooth muscle cell proliferation, stimulated by immune responses, likely contributes to lesion development.
- Understanding these mechanisms is crucial for improving diagnosis and treatment of TACA.
Abstract:
Transplant-associated coronary arteriosclerosis is an obstructive, proliferative lesion that forms in the coronary arteries of transplanted hearts, often within months, and is the most frequent single cause of late posttransplant death. Graft arteriosclerosis has uncertain risk factors, is difficult to diagnose because of the denervation of the transplanted heart, and is difficult to treat because of its diffuse nature, with frequent involvement of intramural as well as extramural vessels. Graft arteriosclerosis is morphologically distinct from the usual form of coronary atherosclerosis, with T-lymphocytes and macrophages in the portions of the lesion immediately beneath an intact endothelium. Nevertheless, like typical atherosclerosis, the obstructive lesions are largely composed of smooth muscle cells and the extracellular matrix that they produce. Immunologic mechanisms likely contribute to graft arteriosclerosis, possibly through cytokine-driven smooth muscle cell proliferation, stimulated by a localized chronic cell-mediated immune response analogous to delayed type hypersensitivity.
